NCT01178944 2017-12-13Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction CancerRoswell Park Cancer InstitutePhase 2 Completed35 enrolled 11 charts